WeVote
Log In

Bill

Bill

SB 3801

PRESCRIPTION LABELING

104th Regular Session Introduced by Graciela Guzmán and 7 co-sponsors

Illinois bill modifying prescription drug labeling requirements; currently in early legislative review stage with unclear specific labeling changes proposed.

Rule 3-9(a) / Re-referred to Assignments
0
WeVote Research Nonpartisan
Bill Summary · SB 3801

Legislative bill overview

SB 3801 modifies requirements for prescription drug labeling in Illinois, though the specific labeling changes are not detailed in the provided information. The bill has recently been introduced and is currently in the early legislative stage, having just completed its first reading and been assigned to the Executive Committee.

Why is this important

Prescription labeling directly affects patient safety and medication adherence by communicating critical information about dosage, side effects, interactions, and usage instructions. Clear, standardized labeling can reduce medication errors, improve health outcomes, and is particularly important for vulnerable populations who may have literacy or language barriers.

Potential points of contention

  • Compliance costs - Pharmacies and manufacturers may face increased expenses if new labeling requirements mandate different printing, materials, or distribution systems
  • Feasibility concerns - Adding extensive information to labels has physical space constraints; balance between comprehensiveness and readability remains difficult
  • Scope of federal vs. state authority - Prescription labeling is heavily regulated federally by the FDA; state-level modifications could create conflicts or require dual-compliance systems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.